4:03 PM · 6 December 2023

InMode shares decline 10% after company profit warning

Israeli medical company Inmode (INMD.US) is trading down more than 10% today, after it lowered its full-year guidance for 2023, citing stronger-than-expected pressure from macroeconomic headwinds.

  • As a result, the company sees lower interest in services in its proprietary medical platform. Inmode now expects $2.47 to $2.5 in annual earnings per share, versus $2.53 to $2.57 previously. Revenues are expected to be in the range of $485 to $495 million vs. $500 to $510 million estimated previously.
  • The company maintains very high net margins, which stood at 36% in Q3, with close to zero debt. Since October 7, shares have plunged due to uncertainty surrounding the conflict in Israel and a broader escalation in the Middle East. The company itself reported that its supply chains, workers and production are safe and the local Israeli market accounts for less than 1% of its total sales.

Source: xStation5

5 June 2026, 3:45 PM

NFP: A turning point for the dollar and the start of a stock market correction?

5 June 2026, 2:49 PM

US Open: Wall Street slides amid semiconductor stocks sell-off 📌Intel down 6%

5 June 2026, 12:44 PM

Market Wrap: SAP bucks tech sell-off, SpaceX blocked from S&P 500 entry (05.06.2026)

5 June 2026, 12:10 PM

Lululemon Athletica slumps 14% after earnings amid weak North America sales 📉

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits